Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel MRE Technique to Assess Tissue Viscoelasticity as a Risk Factor for Liver Cancer

NCT05165446 is registered in ClinicalTrials.gov with Natalie Torok as lead sponsor.

NCT NCT05165446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05165446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel MRE Technique to Assess Tissue Viscoelasticity as a Risk Factor for Liver Cancer
Lead sponsor
Natalie Torok
Phase
Observational
Overall status
Active, not recruiting
Start date
January 27, 2022
Completion date
August 30, 2026
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nash - nonalcoholic steatohepatitis